Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Poster presentation

Acute Serum Amyloid A induces cell migration cytoskeletal rearrangement and Notch signalling in rheumatoid arthritis

Authors: Mary Connolly, Peadar Rooney, Wei Gao, Douglas Veale, Ursula Fearon

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

Acute Serum Amyloid A (A-SAA) is an acute phase protein strongly expressed in rheumatoid arthritis (RA) synovial tissue (ST) critically involved in regulating cell migration and angiogenesis. These processes are dependent on downstream interactions between extracellular matrix and cytoskeletal components. Additionally the Notch signalling pathway has been show to regulate endothelial cell (EC) morphogenesis and is critically involved in vessel formation, branching and morphogenesis. The aim of this study was to examine if A-SAA-induced angiogenesis, cell migration and invasion are mediated by the NOTCH signalling pathways. …
Metadata
Title
Acute Serum Amyloid A induces cell migration cytoskeletal rearrangement and Notch signalling in rheumatoid arthritis
Authors
Mary Connolly
Peadar Rooney
Wei Gao
Douglas Veale
Ursula Fearon
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3611

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue

Oral presentation

Directed induction of chondrogenic cells from mouse dermal fibroblast culture

Poster presentation

Active repression by Blimp1 play an important role in osteoclast differentiation

Oral presentation

Death receptor-induced apoptosis signalling - essential guardian against autoimmune disease

Poster presentation

Maintenance of mitochondrial DNA copy number is essential for osteoclast survival

Poster presentation

Resistance to morphine analgesia and its underlying mechanisms in an experimental mouse model of fibromyalgia

Poster presentation

Association of microRNA-221/222 and -323-3p with rheumatoid arthritis via predictions using the human TNF transgenic mouse model
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits